AVTX
Price
$6.75
Change
+$0.02 (+0.30%)
Updated
Jan 17 closing price
Capitalization
70.88M
MRSN
Price
$0.62
Change
+$0.01 (+1.64%)
Updated
Jan 17 closing price
Capitalization
76.42M
39 days until earnings call
Ad is loading...

AVTX vs MRSN

Header iconAVTX vs MRSN Comparison
Open Charts AVTX vs MRSNBanner chart's image
Avalo Therapeutics
Price$6.75
Change+$0.02 (+0.30%)
Volume$238.02K
Capitalization70.88M
Mersana Therapeutics
Price$0.62
Change+$0.01 (+1.64%)
Volume$7.7M
Capitalization76.42M
AVTX vs MRSN Comparison Chart
Loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTX vs. MRSN commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a Hold and MRSN is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (AVTX: $6.75 vs. MRSN: $0.62)
Brand notoriety: AVTX and MRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTX: 215% vs. MRSN: 194%
Market capitalization -- AVTX: $70.88M vs. MRSN: $76.42M
AVTX [@Biotechnology] is valued at $70.88M. MRSN’s [@Biotechnology] market capitalization is $76.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTX’s FA Score shows that 0 FA rating(s) are green whileMRSN’s FA Score has 0 green FA rating(s).

  • AVTX’s FA Score: 0 green, 5 red.
  • MRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, AVTX is a better buy in the long-term than MRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTX’s TA Score shows that 3 TA indicator(s) are bullish while MRSN’s TA Score has 1 bullish TA indicator(s).

  • AVTX’s TA Score: 3 bullish, 4 bearish.
  • MRSN’s TA Score: 1 bullish, 3 bearish.
According to our system of comparison, AVTX is a better buy in the short-term than MRSN.

Price Growth

AVTX (@Biotechnology) experienced а -3.57% price change this week, while MRSN (@Biotechnology) price change was -14.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

AVTX is expected to report earnings on Apr 01, 2024.

MRSN is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRSN($76.4M) has a higher market cap than AVTX($70.9M). AVTX YTD gains are higher at: -9.152 vs. MRSN (-56.741). AVTX has higher annual earnings (EBITDA): -35.84M vs. MRSN (-68.51M). MRSN has more cash in the bank: 155M vs. AVTX (81.9M). AVTX has less debt than MRSN: AVTX (550K) vs MRSN (31.5M). MRSN has higher revenues than AVTX: MRSN (34.8M) vs AVTX (820K).
AVTXMRSNAVTX / MRSN
Capitalization70.9M76.4M93%
EBITDA-35.84M-68.51M52%
Gain YTD-9.152-56.74116%
P/E Ratio0.07N/A-
Revenue820K34.8M2%
Total Cash81.9M155M53%
Total Debt550K31.5M2%
FUNDAMENTALS RATINGS
AVTX vs MRSN: Fundamental Ratings
AVTX
MRSN
OUTLOOK RATING
1..100
5151
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
6598
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVTX's Valuation (85) in the Pharmaceuticals Other industry is in the same range as MRSN (91) in the Biotechnology industry. This means that AVTX’s stock grew similarly to MRSN’s over the last 12 months.

AVTX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as MRSN (100) in the Biotechnology industry. This means that AVTX’s stock grew similarly to MRSN’s over the last 12 months.

AVTX's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as MRSN (100) in the Biotechnology industry. This means that AVTX’s stock grew similarly to MRSN’s over the last 12 months.

AVTX's Price Growth Rating (65) in the Pharmaceuticals Other industry is somewhat better than the same rating for MRSN (98) in the Biotechnology industry. This means that AVTX’s stock grew somewhat faster than MRSN’s over the last 12 months.

AVTX's P/E Growth Rating (94) in the Pharmaceuticals Other industry is in the same range as MRSN (100) in the Biotechnology industry. This means that AVTX’s stock grew similarly to MRSN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTXMRSN
RSI
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 11 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
89%
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 11 days ago
87%
N/A
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 11 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 11 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 11 days ago
90%
View a ticker or compare two or three
Ad is loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DDS466.9816.18
+3.59%
Dillards
SAGE7.080.11
+1.58%
Sage Therapeutics
ROG95.770.09
+0.09%
Rogers Corp
BNR6.53N/A
N/A
Burning Rock Biotech Limited
INTU604.13-3.14
-0.52%
Intuit

AVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with FGEN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then FGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTX
1D Price
Change %
AVTX100%
+0.30%
FGEN - AVTX
57%
Loosely correlated
-1.14%
MEOBF - AVTX
46%
Loosely correlated
N/A
MRSN - AVTX
37%
Loosely correlated
+0.68%
CELC - AVTX
37%
Loosely correlated
-2.84%
XLO - AVTX
35%
Loosely correlated
N/A
More

MRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRSN has been loosely correlated with IGMS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if MRSN jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRSN
1D Price
Change %
MRSN100%
+0.68%
IGMS - MRSN
53%
Loosely correlated
-3.28%
DYN - MRSN
48%
Loosely correlated
-4.33%
MLYS - MRSN
43%
Loosely correlated
-2.74%
CRNX - MRSN
41%
Loosely correlated
+2.38%
RGNX - MRSN
41%
Loosely correlated
+3.08%
More